Finding the best ECMO flow for cardiogenic shock
Part of Heart & circulation clinical trials.
This study tests whether adjusting the blood flow rate of an ECMO machine (which helps your heart pump) can improve blood flow to your organs and reduce stress on your heart during the critical early phase of cardiogenic shock. It aims to find the best ECMO settings to help you recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have cardiogenic shock — a condition where your heart can't pump enough blood to the rest of your body.
- You must already be on a heart-lung bypass machine (ECMO) and have been on it for less than 48 hours.
- Your shock must not be caused by a heart attack that happened just before starting ECMO (or if it did, the low-flow period must have been 30 minutes or less).
- You must not be on very high doses of heart-support medications (like noradrenaline, vasopressin, dobutamine, or adrenaline).
- Your shock must not be due to heart surgery, severe infection (septic shock), or a hole in the heart (atrial or ventricular septal defect).
- You must not be pregnant or breastfeeding, and you must be able to agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two support devices (Impella vs. IABP) for people with cardiogenic shock who are already on ECMO. It looks at how well the left side of the heart recovers when one of these devices is added.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial is studying whether using less of the medicines that raise blood pressure (vasopressors) can help people with severe heart failure who are on a heart-lung machine (ECMO) survive. It may answer if a gentler approach is safer.
This trial studies people who are starting ECMO, a machine that takes over the work of the heart and lungs, to see if a more tailored approach can improve outcomes. If you join, your care may be adjusted based on your specific needs.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.